scholarly journals Mesenchymal stem cell-derived inflammatory fibroblasts mediate interstitial fibrosis in the aging heart

2016 ◽  
Vol 91 ◽  
pp. 28-34 ◽  
Author(s):  
JoAnn Trial ◽  
Mark L. Entman ◽  
Katarzyna A. Cieslik
2020 ◽  
Author(s):  
Hu Xuemei ◽  
Nan Shen ◽  
Anqi Liu ◽  
Weidong Wang ◽  
Lihua Zhang ◽  
...  

Abstract Renal interstitial fibrosis (RIF) is an incurable pathological lesion in progressive chronic kidney diseases. Myofibroblast proliferation and microvascular damage are two important events in RIF, and pericytes are a major source of myofibroblasts in the kidney. However, the underlying mechanisms remain poorly characterized. We report that core fucosylation (CF), a post-translational modification of proteins, is essential for pericyte activation by regulating profibrotic and antifibrotic signaling pathways as a “hub-like” target. Mesenchymal stem cell (MSC)-derived exosomes reside specifically in the obstructed kidney and deliver microRNA (miR)-34c-5p to inhibit CF, reducing pericyte activation and renal fibrosis. Furthermore, we clarify that the CD81–EGFR ligand–receptor complex aids the entry of exosomal miR-34c-5p into pericytes. Our results reveal a novel mechanism of pericyte activation based on CF and suggest a potential use of MSC exosomes as a new therapeutic strategy for RIF by inhibiting CF, the hub-like target of profibrotic signaling activation.


2012 ◽  
Vol 21 (17) ◽  
pp. 3125-3135 ◽  
Author(s):  
Marcella Franquesa ◽  
Esther Herrero ◽  
Joan Torras ◽  
Elia Ripoll ◽  
Maria Flaquer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document